{"id":"W4387094998","doi":"10.21203/rs.3.rs-3314138/v1","title":"Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institutes of Health; Ovarian Cancer Research Alliance; Astex Pharmaceuticals; Sierra Oncology; Uehara Memorial Foundation; Japan Society for the Promotion of Science; AstraZeneca; Hope Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","keywords":"ARID1A; RAD51; Cancer research; DNA damage; Chromatin; DNA repair; Biology; Synthetic lethality; Homologous recombination; Epigenetics; Cancer; BRD4; Wee1; Cell cycle; Mutation; DNA; Gene; Genetics; Cyclin-dependent kinase 1","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009531634,0.0002421308,0.0003545806,0.0002065986,0.00007959817,0.00004747101,0.0003223977,0.000563429,0.00003742204],"category_scores_gemma":[0.0001497411,0.0002459222,0.0001234638,0.0002194944,0.0001894642,0.000002777565,0.001406359,0.0008545087,0.00001093018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000855485,"about_ca_system_score_gemma":0.0007570643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002989918,"about_ca_topic_score_gemma":0.001086671,"domain_scores_codex":[0.997432,0.0002519687,0.0003926939,0.0007965208,0.000571797,0.0005550068],"domain_scores_gemma":[0.9987015,0.00005516398,0.0001101043,0.000674357,0.000305795,0.0001531035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001230282,0.0006323214,0.03388532,0.01115032,0.0003418795,0.0003016851,0.003486488,0.02094057,0.9002658,0.0001290045,0.01370021,0.01393614],"study_design_scores_gemma":[0.006361487,0.002089308,0.05985039,0.006488255,0.00009922872,0.00003335034,0.004429623,0.01264326,0.8831166,0.004690551,0.01775268,0.002445268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932329,0.004850517,0.00005728161,0.000338584,0.0001818486,0.0004811297,0.000429426,0.00002270028,0.0004055892],"genre_scores_gemma":[0.989783,0.007915254,0.0001921914,0.00001528493,0.0005197279,0.0001771583,0.000243666,0.00007341904,0.001080306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02596507,"threshold_uncertainty_score":0.9999993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08011353551033792,"score_gpt":0.3738866789865019,"score_spread":0.2937731434761639,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}